Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE)

Vaccine ◽  
2022 ◽  
Author(s):  
Jakub K. Simon ◽  
Nina Breinholt Staerke ◽  
Maria Hemming-Harlo ◽  
Stacey Layle ◽  
Ron Dagan ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Healthy Adults ◽  
Phase 3

Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults

Vaccine ◽  
2015 ◽  
Vol 33 (24) ◽  
pp. 2793-2799 ◽  
Author(s):  
Richard McFetridge ◽  
Ajoke Sobanjo-ter Meulen ◽  
Steven D. Folkerth ◽  
John A. Hoekstra ◽  
Michael Dallas ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Healthy Adults

scholarly journals Carriage ofStreptoccoccus pneumoniaein healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children

2013 ◽  
Vol 9 (3) ◽  
pp. 614-620 ◽  
Author(s):  
Filippo Ansaldi ◽  
Daniela de Florentiis ◽  
Paola Canepa ◽  
Antonella Ceravolo ◽  
Emanuela Rappazzo ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Pneumococcal Conjugate Vaccine ◽  
Vaccine Coverage ◽  
Healthy Adults ◽  
Very High
Sign in / Sign up

Export Citation Format

Share Document